Effectiveness of physiotherapy in children with functional constipation

Varsha Garag1, Sanjay Parmar2, B Akshay Kalavant3

  • 1SDM College of Physiotherapy, SDM University, Dharwad, 580009, India.

Insights

A combination of physiotherapy and pharmacological treatment significantly improved symptoms and quality of life in children with functional constipation compared to either treatment alone.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Therapeutics
  • Rehabilitation Medicine

Background:

  • Functional constipation is a common pediatric gastrointestinal disorder.
  • Current treatments include pharmacological and non-pharmacological approaches.
  • Optimal treatment strategies require further investigation.

Purpose of the Study:

  • To compare the efficacy of pharmacological treatment, physiotherapy, and a combination therapy for functional constipation in children.
  • To evaluate the impact on quality of life and symptom recurrence over 3 months.

Main Methods:

  • 69 children (5-14 years) with functional constipation were randomized into three groups.
  • Group A received pharmacological treatment, Group B received physiotherapy, and Group C received a combination.
  • Outcome measures included Visual Analogue Scale, Bristol Stool Form Scale, defecation frequency, and PedsQL scales.

Main Results:

  • All groups showed significant improvements in pain, stool consistency, and defecation frequency.
  • The combination therapy group (Group C) demonstrated significant improvements in GI symptoms and overall quality of life.
  • Pharmacological treatment alone (Group A) did not yield significant improvements in quality of life or GI symptoms.

Conclusions:

  • Combination therapy is more effective than pharmacological or physiotherapy alone for functional constipation in children.
  • Combined treatment offers superior short- and long-term benefits for symptom management and quality of life.
  • Physiotherapy plays a crucial role in improving pediatric functional constipation outcomes.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
157
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
203
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
196
Chest Physiotherapy01:24

Chest Physiotherapy

Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
439
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
195
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
159